COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation
Clinical trial NCT04642430 · RECRUITING
Trial details
- NCT number
- NCT04642430
- Sponsor
- Ottawa Hospital Research Institute
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-06
- Primary completion
- 2027-12-31
- Enrollment
- 3018
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.